What were the key takeaways from Beyond Meat’s earnings call?

What is the revenue and EPS growth rate for Beyond Meat year over year?

What does Beyond Meat do and what are its main business segments?

What were the key takeaways from Beyond Meat's earnings call?

What is the market's earnings forecast for Beyond Meat next quarter?

What guidance did Beyond Meat's management provide for the next earnings period?

What is Beyond Meat's latest dividend and current dividend yield?

Did Beyond Meat beat or miss consensus estimates last quarter?

- **Strategic Pivot to Beverages**: Beyond Immerse protein drink launched Q4 2025, sold out quickly with 10-20g protein, no artificial additives.
- **Category Struggles**: Q4 2025 revenue down 19.7% YoY to $61.6M, driven by weak demand and SKU cuts.
- **Debt Restructuring Success**: $148.7M ATM proceeds and $97.4M debt exchange reduced financial risk, though EBITDA loss widened to $69M.
- **Consumer Feedback-Driven Innovation**: Iterative product development for Beyond Immerse, with 6-7 iterations based on taste tests.
- **Adjacent Market Expansion**: CEO signals future adjacencies beyond beverages, leveraging R&D for protein innovation in health/wellness.

**【CEO Summary Section】**
- CEO Ethan Brown emphasized the company's pivot to adjacent markets, launching the Beyond Immerse protein drink in Q4 2025, which sold out quickly and received positive consumer feedback.
- The plant-based meat category faced persistent headwinds, with Q4 revenue down 19.7% YoY to $61.6M, driven by weak demand and SKU rationalization.
- Management highlighted the importance of clean ingredients and innovation, with Beyond Immerse containing 10-20g of protein, fiber, antioxidants, and no artificial additives.
- The company is exploring additional adjacencies beyond beverages, with a focus on leveraging its brand and R&D capabilities.

**【CFO Financial Commentary】**
- CFO Lubi Kutua reported Q4 2025 net loss of $409.9M, including $48.1M in asset write-downs and $13.3M in stock comp expenses.
- Adjusted EBITDA loss widened to $69M due to higher COGS and operating expenses, though non-cash charges skewed results.
- The debt exchange reduced financial risk, with $148.7M raised via ATM and $97.4M of 2027 notes exchanged for 2030 notes.
- Cash flow management remains a priority, with Q4 cash use of $144.9M for the year, partially offset by $12.3M in capex.

**【Q&A Key Highlights】**
- **Beverage Expansion**: CEO detailed iterative product development for Beyond Immerse, with 6-7 iterations based on consumer feedback. The 20g protein version was more polarizing, leading to flavor adjustments.
- **Core Business Challenges**: QSR and retail channels saw volume declines, with no immediate recovery in plant-based meat category.
- **Balance Sheet Strength**: CFO highlighted reduced leverage and improved liquidity post-debt exchange, though EBITDA remains negative.
- **Cost Management**: Focus on inventory optimization and SKU rationalization to reduce operating expenses.
- **Adjacent Market Potential**: CEO hinted at future adjacencies beyond beverages, leveraging Beyond's R&D for protein innovation in health/wellness sectors.

Beyond Meat, Inc. (BYND) Q4 2025 Earnings Call Transcript

- **Balance Sheet Restructuring**: 90% debt reduction to $209M, extended maturity, and new covenant package.
- **Gross Margin Reset**: Targeting 30%+ in 2026 with continuous production lines and RFP savings.
- **Cash Position**: ~$80-90M post-transaction, with reduced cash burn from normalized OpEx.
- **Strategic Shift**: Simplified products (e.g., 4-ingredient Beyond Ground), direct-to-consumer testing, and health-focused marketing.
- **Financial Health**: Q3 2025 GAAP net loss of $110.7M (including $77.4M impairment), with adjusted EBITDA loss of $21.6M (-30.8% of revenue).

**【Management Opening Remarks】**
- The call opened with procedural announcements and a brief overview of the earnings release, noting that all forward-looking statements are subject to risks and uncertainties. The company emphasized the importance of non-GAAP financial measures and provided a reconciliation to GAAP metrics.

**【CEO Commentary】**
- **Revenue Performance**: Q3 2025 net revenue of $70.2 million (-13% YoY) due to category-wide demand weakness and distribution losses. Gross margin declined to 10.3% (vs. 17.7% YoY) due to lower volume, trade discounts, and non-cash charges related to China operations.
- **Strategic Reset**: CEO highlighted a fundamental balance sheet reset through debt exchange offers and ATM sales, reducing debt by ~90% and extending maturity. CEO emphasized a shift to cleaner, simpler products (e.g., Beyond Ground with 4 ingredients) and direct-to-consumer testing via Beyond Test Kitchen.
- **Operational Transformation**: Implementation of continuous production lines, RFP-driven cost reductions, and headcount reductions targeting 30%+ gross margin in 2026.
- **Narrative Shift**: Focus on health credentials (28g protein, <1g sat fat) and direct-to-consumer innovation to counter misinformation.

**【CFO Commentary】**
- **Financial Health**: Q3 2025 GAAP net loss of $110.7 million (including $77.4M impairment) vs. $26.6M YoY. Adjusted EBITDA loss of $21.6M (-30.8% of revenue). Cash balance of $131.1M post-transaction.
- **Balance Sheet Restructuring**: $1.1B debt reduction through exchange offers and ATM sales. Remaining debt extended to 2027 with new covenant package.
- **Cost Optimization**: Conversion costs down YoY, logistics savings, and material cost RFPs expected to benefit 2026 margins.

**【Q&A Highlights】**
- **Gross Margin Path**: CEO expects 30%+ in 2026 with continuous production lines and RFP savings. Current drag from lower volume absorption and trade discounts.
- **Cash Position**: Post-transaction cash ~$0-90M (excluding restricted). CFO expects reduced cash burn as OpEx normalizes post-impairment.
- **China Operations**: $1.7M Q3 charges for suspended operations. No plans to restart.
- **Competitive Pricing**: Europe pricing at parity with animal protein. U.S. focus on health narrative vs. price competition.
- **Investor Support**: CEO thanked retail investors for ~$50M ATM participation, signaling long-term alignment.


Beyond Meat, Inc. (BYND) Q3 2025 Earnings Call Transcript

- **Revenue Plunge**: Q2 2025 revenue ($75M) down 19.6% YoY, driven by U.S. retail (-26.7%) and international foodservice (-25.8%).
- **Gross Margin Squeeze**: 11.5% vs. 14.7% YoY, due to lower volumes and China suspension costs.
- **Strategic Reset**: Targeting EBITDA-positive by mid-2026 with $30M+ OpEx run rate, workforce reduction, and 'Beyond' brand expansion.
- **Cash Challenges**: Q2 net cash used $59.4M, with $19M non-recurring expenses. $117.3M cash on hand as of June 2025.

**【CEO Summary Section】**
- **Q2 Revenue Disappointment**: Net revenue of $75 million, down 19.6% YoY, driven by U.S. retail channel decline (26.7%) and international foodservice softness. Gross margin fell to 11.5% from 14.7% YoY due to lower volumes and unfavorable product mix.
- **Strategic Reset**: Goals include EBITDA-positive operations by mid-2026. Key actions: 
  - Appointed John Boken as interim Chief Transformation Officer to lead cost reduction and gross margin expansion.
  - Reduced workforce to cut operating expenses; non-recurring Q2 expenses totaled $7.5 million.
  - Optimizing product portfolio by exiting low-margin lines and reconfiguring production for current demand.
  - Shifting to 'Beyond' brand focus to expand beyond meat replicas (e.g., Beyond Ground with 27g protein, no oil).
- **Challenges**: Higher pricing vs. animal protein, misinformation impact, and category-wide disruption in U.S. retail (e.g., refrigerated to frozen aisle relocation).

**【CFO Financial Commentary】**
- **Revenue Breakdown**: U.S. retail (-26.7%), U.S. foodservice (+6.8%), international retail (-9.8%), international foodservice (-25.8%).
- **Gross Margin Pressure**: 11.5% vs. 14.7% YoY, driven by reduced volume absorption and $1.7 million China suspension costs.
- **Operating Expenses**: $47.4 million (flat YoY) but included $4.5M retention costs, $2.5M legal fees, and $0.5M lease termination.
- **Cash Flow**: Q2 net cash used $59.4M (vs. $47.8M YoY), with $40M drawn from Unprocessed Foods loan. Cash balance $117.3M as of June 28, 2025.
- **Balance Sheet Focus**: Addressing 2027 convertible note maturity through potential transactions.

**【Q&A Highlights】**
- **EBITDA Path and Top Line Growth**: CEO emphasizes cost reduction (targeting $30M+ OpEx run rate) and distribution expansion in U.S. retail. New product innovation (e.g., Beyond Ground) aims to capture protein-focused consumers despite near-term revenue headwinds.
- **Cash Management**: CFO notes Q2 cash burn included $19M non-recurring expenses. Focus on reducing underlying cash consumption while pursuing balance sheet strengthening.
- **International Foodservice Softness**: Lapping promotional activity and QSR menu shifts to cheaper animal protein. Expect ongoing pressure but maintaining partnerships.
- **Workforce Restructuring**: CEO clarifies headcount increase reflects in-house manufacturing (down from 13 co-packers to 1) and international expansion, not inefficiency.

Beyond Meat, Inc. (BYND) Q2 2025 Earnings Call Transcript

- **Revenue Decline**: Q1 2025 net revenues fell 9.1% to $68.7M due to U.S. retail and food service channel weakness.
- **Strategic Initiatives**: 
  - **Real People, Real Results Campaign**: Track health outcomes via social media.
  - **$100M Debt Facility**: High-cost debt with 12% interest initially.
- **Key Risks**: Distribution losses, macroeconomic consumer confidence challenges.
- **Focus**: Stabilize margins and achieve 2026 EBITDA positivity.

**【Management Opening Remarks】**
- The call outlines the structure, participants, and key themes for discussion, emphasizing strategic initiatives and financial challenges.

**【CEO Commentary】**
- **Revenue Decline**: Q1 2025 net revenues fell 9.1% to $68.7 million, driven by U.S. retail and food service channel weakness.
- **Distribution Challenges**: Two large retailers transitioned products from refrigerated to frozen sections, impacting velocity and gross margin.
- **Strategic Initiatives**: 
  - **Real People, Real Results Campaign**: A 30-day plant-based diet challenge with health outcomes tracked on social media.
  - **New Financing**: $100M senior secured debt facility with high interest rates (12% initially, 17.5% post-2030), but no near-term maturities.

**【CFO Financial Commentary】**
- **Top-Line Pressure**: 
  - U.S. Retail: 15.4% revenue decline due to distribution losses and macroeconomic headwinds.
  - U.S. Food Service: 23.5% decline from volume reductions and pricing actions.
- **Gross Margin Issues**: 
  - 1.5% loss (vs. 4.9% YoY) due to lower sales volume, production mix, and strategic inventory provisions.
  - Operating expenses ($55.1M) include $7.2M in one-time charges (legal, China suspension costs).
- **Balance Sheet**: $115.8M cash, $1.1B total debt, and $26.1M net cash used in operations.

**【Q&A Highlights】**
1. **Distribution Recovery**: Management expects to regain 70% of lost U.S. retail distribution by Q4 2025.
2. **Consumer Behavior**: Softness in protein category demand linked to macroeconomic uncertainty.
3. **Debt Strategy**: Focus on EBITDA positivity, with no immediate plans to address 2027 convertible notes.
4. **China Operations**: Ongoing suspension costs treated as accelerated depreciation through 2026.


Beyond Meat (BYND)-7 May 25-2025 Q1 Earnings call transcript

- **Revenue Resilience**: Q4 2024 net revenue up 4% to $76.7M, with U.S. retail +5.7% despite macro challenges. 
- **Gross Margin Turnaround**: 2024 gross margin improved to 12.8% (vs. -113.8% in Q4 2023), targeting 20% in 2025. 
- **Cost Efficiency**: Operating expenses reduced by $50M in 2024, with further cuts planned to achieve 2026 EBITDA-positive. 
- **Strategic Shifts**: Paused China operations, prioritized Europe expansion (France Beyond Steak launch), and leaner go-to-market strategy. 
- **Health Focus**: Consumer shift to clean-label, science-backed products (e.g., American Heart Association-certified Beyond Steak).

**【CEO Summary Section】**
- **2024 Yearly Performance**: Net revenue of $326.5 million (-4.9% YoY), with Q4 revenue growth of 4% to $76.7 million. Gross margin improved to 12.8% (from -113.8% in Q4 2023), driven by COGS per pound reduction to $3.91 (Q4 2024) from $4.48 (Q4 2023). 
- **2025 Strategic Goals**: 
  1. **Revenue Stability**: Target comparable net revenue with focus on EBITDA-positive operations. 
  2. **Gross Margin Expansion**: Aim for 20% in 2025, with long-term goal >30%, via production optimization and pricing. 
  3. **Cost Reduction**: Further cut operating expenses by $50M+ over 2025-2026, including RIF and suspending China operations. 
  4. **Balance Sheet Strength**: Evaluate capital structure improvements to achieve 2026 EBITDA-positive run rate. 
- **Market Momentum**: France retail expansion (Beyond Steak launch), Europe QSR partnerships (McDonald's Veggie McPlant Nuggets), and U.S. retail price increases (+6.3% net revenue per pound). 

**【CFO Financial Commentary】**
- **Q4 2024 Results**: 
  - Net revenue: $76.7M (+4% YoY). 
  - Gross margin: 13.1% (vs. -113.8% YoY). 
  - Operating expenses: $47.8M (-29.1% YoY). 
  - Adjusted EBITDA loss: $26M (-79% YoY). 
- **2025 Guidance**: 
  - Net revenue: $320-335M. 
  - Gross margin: ~20%. 
  - Operating expenses: $160-180M. 
  - Capital expenditures: $15-20M. 
- **Liquidity**: $145.6M cash (Dec 2024), with ATM program generating $46.7M in Q4 2024. 

**【Q&A Key Themes】**
- **Consumer Perception**: Health-focused messaging driving U.S. retail growth (+5.7% Q4 2024), despite broader category noise. 
- **China Suspension Impact**: No revenue breakout, but 2025 guidance reflects strategic focus on EBITDA over growth. 
- **Gross Margin Drivers**: Full-year price increases, production consolidation, and automation investments. 
- **Europe Growth**: France leading with +27% plant-based adoption, Beyond Steak retail launch, and QSR partnerships. 
- **Balance Sheet Strategy**: Evaluating debt restructuring to support 2026 EBITDA-positive target.

Actual					0.03	-0.16	-0.31	-0.4	-0.43	-0.31	-0.87	-1.27	-1.58	-1.53	-1.6	-1.05	-0.92	-0.83	-1.09	-2.4	-0.84	-0.53	-0.41	-0.65	-0.69	-0.43	-1.44	-0.29
Forecast					-0.0667	-0.0196	0.0546	-0.1365	-0.1825	-0.2284	-0.3751	-0.695	-0.9705	-1.3216	-1.1467	-1.1806	-1.0137	-0.8423	-0.8867	-0.892	-0.6663	-0.525	-0.4765	-0.4466	-0.4634	-0.385	-0.3967	-0.1003
Surprise	0.00%	0.00%	0.00%	0.00%	+144.98%	-716.33%	-667.77%	-193.04%	-135.62%	-35.73%	-131.94%	-82.73%	-62.80%	-15.77%	-39.53%	+11.06%	+9.24%	+1.46%	-22.93%	-169.06%	-26.07%	-0.95%	+13.96%	-45.54%	-48.90%	-11.69%	-262.99%	-189.13%

BYND

BYND fundamentals

BYND Q4 2025 Earnings

Earnings Call

You can ask Aime

BYND

BYND fundamentals

BYND Q4 2025 Earnings

Earnings Call

BYND Earnings Call Summary for Q4/20255:00 PM on Mar 25, 2026

BYND Earnings Call Summary for Q3/20255:00 PM on Nov 11, 2025

BYND Earnings Call Summary for Q2/20255:00 PM on Aug 6, 2025

BYND Earnings Call Summary for Q1/20255:00 PM on May 7, 2025

BYND Earnings Call Summary for Q4/20245:00 PM on Feb 26, 2025

You can ask Aime